To include your compound in the COVID-19 Resource Center, submit it here.

Agency to clarify risk-benefit determinations for devices

FDA issued draft guidance that seeks to clarify how

Read the full 94 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE